The invention relates to a solid pharmaceutical preparation form containingone or more solid excipients and/or adjuvants and an active substance from thegroup consisting of monoamine neurotransmitter reuptake inhibitors that have a2,3-disubstituted tropane skeleton. The invention also relates the productionof this preparation form and to the use thereof for producing a medicament fortreating or preventing central nervous system diseases or disorders.
